Joinn Laboratories China Co., Ltd. (603127)

Overview

Joinn Laboratories(China)Co.,Ltd. is a prominent provider of preclinical and non-clinical services, catering to an international clientele that includes the United States and the People's Republic of China. Since its inception in 1995, the company has grown to operate through three main segments, which encompass Non-Clinical Studies Services, Clinical Trial and Related Services, and Sales of Research Models. With its headquarters in Beijing, China, Joinn Laboratories is dedicated to supporting the development of new drugs by offering comprehensive services ranging from drug safety assessment to the sales of research models. Through its vast range of services, Joinn Laboratories plays a crucial role in the drug development process, catering to pharmaceutical and biotechnology companies globally.

Products and Services

• Non-Clinical Studies Services: This segment is devoted to aiding drug development efforts through a variety of critical studies. It includes drug safety assessment, where the potential risks of new drugs are evaluated; drug metabolism and pharmacokinetics (DMPK) studies, which analyze how drugs are absorbed, distributed, metabolized, and excreted in the body; and pharmacology and efficacy studies, which assess the biological activity and efficacy of drug candidates.

• Clinical Trial and Related Services: Joinn Laboratories offers comprehensive services that support clinical trials, including Contract Research Organization (CRO) services that cover a wide range of clinical trial needs. The company also has co-managed phase I clinical research units, which specialize in the initial phase of clinical trials to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug in humans. Additionally, bioanalytical services are provided to support the analysis of drugs and their metabolites in biological samples.

• Sales of Research Models: This segment caters to the need for high-quality research models in the drug development process. Joinn Laboratories designs, produces, breeds, and sells a variety of research models, including non-human primates and rodents. These models are crucial for preclinical testing and other research applications, providing valuable insights into drug safety and efficacy before human trials commence.

• Cell-Based Assay (CBA) Services: The company also specializes in cell-based assay services, which are vital for evaluating the cellular response to drugs. These assays are an essential tool in drug discovery and development, helping to elucidate mechanisms of action, verify drug efficacy, and screen for cytotoxicity.